JP Patent

JP6198821B2 — デフィブロチドの生物学的活性を決定する為の、ユーグロブリンに基づく方法

Assigned to ゲンチウム エス．アール．エル． · Expires 2017-09-20 · 9y expired

What this patent protects

Patent listed against defibrotide-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP6198821B2
Jurisdiction
JP
Classification
—
Expires
2017-09-20
Drug substance claim
No
Drug product claim
No
Assignee
ゲンチウム エス．アール．エル．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.